Trial intelligence / Profile preview

BELCANTO

2024-518917-24-00Phase 2Completed

Sponsor: Universitätsklinikum Schleswig-Holstein
Start: Nov 2024
Modality: Small Molecules
Countries: 1

Overview

Phase 2, randomised, double-blind trial in cancer pain, anorexia nervosa (AN), cancer-related fatigue (CRF) and 2 more comparing Cannabis Extract Avextra 10/10 with Placebo (Sesamöl-Leinöl-Mischung PL 01) (2 arms). Started Nov 2024; status: completed.

Drugs

Avextra 10/10

Conditions

cancer painanorexia nervosa (AN)cancer-related fatigue (CRF)Insomniadistress

Beyond the preview

Go deeper on 2024-518917-24-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-518917-24-00.